SCHEMBL22911981

SCHEMBL22911981

O=[N+]([O-])c1ccc2c(N3CCCC3)nncc2c1

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.47
LMNA P02545 4/20 0.47
MAPK1 P28482 3/20 0.47
HTT P42858 1/20 0.47
MAPT P10636 5/20 0.47
NPC1 O15118 1/20 0.46
APOBEC3A P31941 1/20 0.46
RAB9A P51151 1/20 0.46
APOBEC3G Q9HC16 1/20 0.46
GAA P10253 2/20 0.46
ALOX12 P18054 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ACHE P22303 1/20 0.44
POLB P06746 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
SMN1; SMN2 Q16637 2/20 0.42
NPBWR1 P48145 1/20 0.41
KMT2A Q03164 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24704588 0.82 MAT2A (0.41) ALDH1A1LMNAMAPTSMN1; SMN2KMT2A
SCHEMBL22911949 0.80 ALDH1A1 (0.51) ALDH1A1LMNAMAPK1HTTMAPT
SCHEMBL13701031 0.77 TSHR (0.45) ALDH1A1LMNAHTTMAPTACHE
SCHEMBL28729733 0.77 RHOA (0.41) ALDH1A1LMNAHTTMAPTPOLB
SCHEMBL2945973 0.76 MAPK14 (0.61) ALDH1A1LMNAMAPK1HTTMAPT
SCHEMBL22912018 0.76 KMT2A (0.49) ALDH1A1LMNAMAPTGAAPOLB
SCHEMBL29596511 0.76 KMT2A (0.49) ALDH1A1LMNAMAPTGAAPOLB
Trifluoroacetic Acid SCHEMBL28729299 0.74 C1S (0.45) ALDH1A1LMNAHTTMAPTTDP1
Trifluoroacetic Acid SCHEMBL29595902 0.74 C1S (0.45) ALDH1A1LMNAHTTMAPTTDP1
Trifluoroacetic Acid SCHEMBL28729295 0.74 C1S (0.45) ALDH1A1LMNAHTTMAPTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021011796-A1 INHIBITORS OF CYCLIN-DEPENDENT KINASES KINNATE BIOPHARMA INC. (US) 2021-01-21 WO disclosed